Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BUSCLAB – Butylscopolamine bromide for slow progress in labor
2018-002338-19Phase 3Completed
- Sponsor
- Oslo University Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in labor dystocia comparing Buscopan arm with Placebo arm (2 arms). Primary endpoint: Duration from investigational medicinal product administration to full cervical dilatation. Started Jul 2018; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
labor dystocia
Beyond the preview
Go deeper on 2018-002338-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002338-19.